Publications by authors named "Julia Karlsson"

Claim this Profile
D
Development of forecast models for COVID-19 hospital admissions using anonymized and aggregated mobile network data.
Jalil Taghia, Valentin Kulyk, Selim Ickin, Mats Folkesson, Cecilia Nyström, Julia Karlsson

Sci Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting regional COVID-19 hospital admissions in Sweden using mobility data.
Philip Gerlee, Julia Karlsson, Ingrid Fritzell, Thomas Brezicka, Armin Spreco

Sci Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
Pär Hallberg, Lars Lind, Katarina Billberger, Karl Michaelsson, Julia Karlsson

Clin Cardiol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.
Lisa Kurland, Ulrika Liljedahl, Julia Karlsson, Thomas Kahan, Karin Malmqvist

Am J Hypertens· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
Pär Hallberg, Lars Lind, Karl Michaëlsson, Julia Karlsson, Lisa Kurland

J Hypertens· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response.
Ulrika Liljedahl, Julia Karlsson, Håkan Melhus, Lisa Kurland, Marie Lindersson

Pharmacogenetics· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.
Pär Hallberg, Julia Karlsson, Lisa Kurland, Lars Lind, Thomas Kahan

J Hypertens· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
Lisa Kurland, Håkan Melhus, Julia Karlsson, Thomas Kahan, Karin Malmqvist

Am J Hypertens· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
Lisa Kurland, Håkan Melhus, Julia Karlsson, Thomas Kahan, Karin Malmqvist

J Hypertens· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis